AR005999A1 - Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos - Google Patents

Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos

Info

Publication number
AR005999A1
AR005999A1 ARP970100760A ARP970100760A AR005999A1 AR 005999 A1 AR005999 A1 AR 005999A1 AR P970100760 A ARP970100760 A AR P970100760A AR P970100760 A ARP970100760 A AR P970100760A AR 005999 A1 AR005999 A1 AR 005999A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
preparation procedure
erythromycin
medicines
compounds
Prior art date
Application number
ARP970100760A
Other languages
English (en)
Spanish (es)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of AR005999A1 publication Critical patent/AR005999A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ARP970100760A 1996-02-28 1997-02-25 Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos AR005999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
AR005999A1 true AR005999A1 (es) 1999-07-21

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100760A AR005999A1 (es) 1996-02-28 1997-02-25 Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos

Country Status (31)

Country Link
US (1) US6096714A (enExample)
EP (1) EP0885234B1 (enExample)
JP (1) JP4102440B2 (enExample)
KR (1) KR100486053B1 (enExample)
CN (1) CN1168734C (enExample)
AP (1) AP952A (enExample)
AR (1) AR005999A1 (enExample)
AT (1) ATE217633T1 (enExample)
AU (1) AU716204B2 (enExample)
BG (1) BG63207B1 (enExample)
BR (1) BR9707709B1 (enExample)
CZ (1) CZ293893B6 (enExample)
DE (1) DE69712610T2 (enExample)
DK (1) DK0885234T3 (enExample)
EA (1) EA001376B1 (enExample)
EE (1) EE9800265A (enExample)
ES (1) ES2176698T3 (enExample)
FR (1) FR2745290B1 (enExample)
HU (1) HU227567B1 (enExample)
IL (1) IL125622A (enExample)
NO (1) NO983955D0 (enExample)
NZ (1) NZ331600A (enExample)
OA (1) OA10845A (enExample)
PL (1) PL191736B1 (enExample)
PT (1) PT885234E (enExample)
SK (1) SK118498A3 (enExample)
TR (1) TR199801713T2 (enExample)
UA (1) UA58504C2 (enExample)
WO (1) WO1997031929A1 (enExample)
YU (1) YU37098A (enExample)
ZA (1) ZA971659B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA989835B (en) * 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
WO1999021870A1 (en) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
AP2001002222A0 (en) 1999-01-27 2001-09-30 Pfizer Prod Inc Ketolide antibiotics.
IL145739A0 (en) * 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
WO2001010880A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6183700A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010879A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8796232B2 (en) * 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
CN103080122A (zh) 2010-03-22 2013-05-01 森普拉制药公司 大环内脂的结晶形式及其用途
WO2011146829A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
WO2014145210A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
PL191736B1 (pl) 2006-06-30
TR199801713T2 (xx) 1998-12-21
DK0885234T3 (da) 2002-08-26
PT885234E (pt) 2002-10-31
HUP9902576A3 (en) 2001-03-28
HUP9902576A1 (hu) 1999-12-28
ZA971659B (en) 1998-02-26
DE69712610T2 (de) 2002-11-28
OA10845A (fr) 2003-02-05
EP0885234B1 (fr) 2002-05-15
IL125622A (en) 2003-10-31
AP952A (en) 2001-03-29
EA001376B1 (ru) 2001-02-26
KR19990087324A (ko) 1999-12-27
AU1929897A (en) 1997-09-16
EE9800265A (et) 1999-02-15
CN1168734C (zh) 2004-09-29
AU716204B2 (en) 2000-02-24
EA199800768A1 (ru) 1999-02-25
BR9707709B1 (pt) 2014-10-14
SK118498A3 (en) 1999-07-12
NO983955L (no) 1998-08-27
JP4102440B2 (ja) 2008-06-18
YU37098A (sh) 1999-07-28
EP0885234A1 (fr) 1998-12-23
NO983955D0 (no) 1998-08-27
IL125622A0 (en) 1999-04-11
FR2745290A1 (fr) 1997-08-29
BR9707709A (pt) 1999-04-06
FR2745290B1 (fr) 1998-04-03
WO1997031929A1 (fr) 1997-09-04
US6096714A (en) 2000-08-01
CZ293893B6 (cs) 2004-08-18
BG102691A (en) 1999-06-30
ES2176698T3 (es) 2002-12-01
JP2000505469A (ja) 2000-05-09
BG63207B1 (bg) 2001-06-29
AP9801318A0 (en) 1998-09-30
PL328608A1 (en) 1999-02-01
NZ331600A (en) 1999-08-30
DE69712610D1 (de) 2002-06-20
HU227567B1 (en) 2011-08-29
UA58504C2 (uk) 2003-08-15
CN1212700A (zh) 1999-03-31
CZ258798A3 (cs) 1998-12-16
ATE217633T1 (de) 2002-06-15
KR100486053B1 (ko) 2005-06-16

Similar Documents

Publication Publication Date Title
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
DE69324305D1 (de) Zyklische Adhäsionsinhibitoren
ES2176698T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
AU591309B2 (en) Taxol derivatives, their preparation and pharmaceutical compositions containing them
TR199901578T2 (xx) Klaritromisin form 0 kristali
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
HUP0001232A2 (hu) Béta-amiloid peptid kibocsátást és/vagy szintézist gátló cikloalkil-, laktám-, laktonszármazékok, és ezek tio-analógjai, valamint e vegyületeket tartalmazó gyógyászati készítmények
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
FI963916L (fi) Uudet stabiloidut galeeniset formulaatiot, jotka sisältävät happolabiilia bentsimidatsoliyhdistettä, ja niiden valmistus
EP0620251A3 (en) Miscible polyolefin blends.
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
FI913556A0 (fi) Nya piperidyletrar och -tioetrar som inhibitorer av kolesterolbiosyntes.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
TR199701298T1 (xx) Tetralinler.